Pentraxin-3 as a predictive marker of mortality in sepsis: an updated systematic review and meta-analysis
Abstract Background The purpose of this study was to clarify the prognostic value of Pentraxin-3 (PTX3) on the mortality of patients with sepsis. Methods Publications published up to January 2021 were retrieved from PubMed, EMBASE, and the Cochrane library. Data from eligible cohort and case–control...
Main Authors: | Guobin Wang, Chunyan Jiang, Junjun Fang, Zhitao Li, Hongliu Cai |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-06-01
|
Series: | Critical Care |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13054-022-04032-x |
Similar Items
-
The Long Pentraxin PTX3 as a Humoral Innate Immunity Functional Player and Biomarker of Infections and Sepsis
by: Rémi Porte, et al.
Published: (2019-04-01) -
Diagnostic value of Pentraxin-3 in patients with sepsis and septic shock in accordance with latest sepsis-3 definitions
by: Sonja Hamed, et al.
Published: (2017-08-01) -
A Comparative Study of the Effectiveness of Serum C-reactive Protein and Serum Pentraxin-3 Levels in the Diagnosis and Follow-up of Neonatal Sepsis
by: Tugrul Atay, et al.
Published: (2022-01-01) -
Association of Plasma Pentraxin-3 Levels on Admission with In-hospital Mortality in Patients with Acute Type A Aortic Dissection
by: Qin Zhou, et al.
Published: (2016-01-01) -
Utility of Elevated Pentraxin-3 Level as Inflammatory Marker for Predicting Adverse Outcomes in Patients With Acute Coronary Syndrome: A Meta-Analysis
by: Yu Fan, et al.
Published: (2022-01-01)